PsoProtect is an international registry developed to enable clinicians to report outcomes of COVID-19 in individuals with psoriasis. It is hoped that PsoProtect will help us to understand how immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis and it will provide real-time updates on cases reported for the benefit of the dermatology community. PsoProtect seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis.
IPC is pleased to be part of this important initiative and asks if you have a psoriasis patient diagnosed with COVID-19, please contribute to this important registry by submitting your case using the online PsoProtect case report form.
In addition, an adjoining registry PsoProtectMe has been set up for patients to self-report their experiences.
View summary data from the first 50 cases
View summary data from the first 200 cases
View current data
WATCH NOW Catherine Smith, MD, and Savteer Mahil, MD, talk to IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD, about their goals for the PsoProtect patient registry to study COVID-19 and psoriasis.
Latest news PsoProtect registry data on first 200 casesOctober 15, 2020PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data so that it now includes the first 200 cases. Commentary: National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic DiseaseOctober 06, 2020IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National Psoriasis Foundation COVID-19 Task Force. Psoriasis experts bust some myths about the diseaseOctober 05, 2020Christopher EM Griffiths and Mahira Hamdy El Sayed use science to counter misinformation about psoriasis. These two dermatologists discuss natural treatments for psoriasis, how lifestyle can affect the immune system, and the rosy future of psoriasis treatment. In Memory of Wolfram Sterry, MD, PhDSeptember 24, 2020Prof. Wolfram Sterry passed away in Munich on September 19, 2020. He was 71. We send our sincerest condolences to Prof. Sterry's family and friends. More News
